Home › Funds › Siren, L.L.C. › SLN
Siren, L.L.C. position in SLN
Silence Therapeutics PLC · Health Care
Siren, L.L.C. reported holding 2,887,867 shares of SLN (Silence Therapeutics PLC) in its Q3 2026 13F filing — a position valued at US$31.6M, representing 0.75% of its reported portfolio and ranking #33 among its reported holdings. Siren, L.L.C. has disclosed SLN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s SLN position evolved
Siren, L.L.C. first disclosed a stake in SLN in Q3 2024 at 2,831,770 shares (US$51.5M). Across 9 filings, Siren, L.L.C. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,887,867 shares valued at US$31.6M — a reduction of -423,571 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 2.83M | $51.48M | New |
| Q4 2024 | 2.83M | $19.48M | Hold |
| Q1 2025 | 2.79M | $7.87M | Reduce |
| Q2 2025 | 2.91M | $16.89M | Add |
| Q3 2025 | 2.91M | $15.11M | Hold |
| Q4 2025 | 2.91M | $17.70M | Hold |
| Q1 2026 | 2.91M | $15.34M | Hold |
| Q2 2026 | 3.31M | $36.36M | Add |
| Q3 2026 | 2.89M | $31.56M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLN and 13F data
SLN (Silence Therapeutics PLC) is a Health Care company. 35 other funds we track also report a position in SLN — the largest reported positions include TCG Crossover Management, LLC (US$33.3M), Redmile Group, LLC (US$23.8M), Nantahala Capital Management, LLC (US$14.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLN
- TCG Crossover Management, LLC 3.03M sh · $33.31M · Q2 2026
- Redmile Group, LLC 2.16M sh · $23.77M · Q2 2026
- Nantahala Capital Management, LLC 1.35M sh · $14.79M · Q2 2026
- Nextech Invest Ltd. 952.40K sh · $10.46M · Q2 2026
- 5AM Venture Management, LLC 476.20K sh · $5.23M · Q2 2026
- GREAT POINT PARTNERS LLC 450.00K sh · $4.94M · Q2 2026
- Tetragon Partners GP Ltd 300.00K sh · $3.29M · Q2 2026
- Ishara Investments LP 55.35K sh · $2.43M · Q2 2026
- Propel Bio Management, LLC 191.73K sh · $2.11M · Q2 2026
- M28 Capital Management LP 101.20K sh · $1.11M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held SLN?
Siren, L.L.C. has disclosed SLN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Siren, L.L.C.'s current position in SLN?
As of Q3 2026, Siren, L.L.C. holds 2.89M shares of SLN (Silence Therapeutics PLC), valued at $31.56M, representing 0.75% of its reported portfolio and ranking #33.
Has Siren, L.L.C. been buying or selling SLN?
In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in SLN.
Which other funds hold SLN?
Other major institutional holders of SLN include TCG Crossover Management, LLC, Redmile Group, LLC, Nantahala Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.